235 related articles for article (PubMed ID: 4154320)
1. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
Bruck J; Guss H
Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320
[No Abstract] [Full Text] [Related]
2. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
[No Abstract] [Full Text] [Related]
3. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
Zwanikken GJ
Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
[No Abstract] [Full Text] [Related]
4. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].
Mormont C
Acta Psychiatr Belg; 1972 Sep; 72(5):595-601. PubMed ID: 4669431
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].
Floru L; Zurborn R
Med Welt; 1973 Apr; 24(15):600-3. PubMed ID: 4744987
[No Abstract] [Full Text] [Related]
6. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
White AC; Sims AC
Curr Med Res Opin; 1974; 2(1):23-6. PubMed ID: 4841811
[No Abstract] [Full Text] [Related]
7. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
Ota KY; Kurland AA; Slotnick VB
J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986
[No Abstract] [Full Text] [Related]
8. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
Vandecasteele AJ; Vereecken JL
Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
[No Abstract] [Full Text] [Related]
9. [Report on the clinical test of the long-term neuroleptic agent penfluridol].
Glatzel J
Med Welt; 1973 Dec; 24(51):2044-6. PubMed ID: 4204355
[No Abstract] [Full Text] [Related]
10. [Long term neuroleptic therapy using fluspirilene and penfluridol].
Haase HJ; Fischer D; Floru L; Frank T; Joseph K; Knaack M; Mohr W; Richter-Peill H; Steuer A; Wahl G; Walterbusch G; Zurborn R
Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761
[No Abstract] [Full Text] [Related]
11. Interaction between neuroleptic therapy and sociotherapeutic approach an investigation with penfluorid and haloperidol.
van Lommel R; Dom R; Baro F
Act Nerv Super (Praha); 1974 Mar; 16(1):75-6. PubMed ID: 4454953
[No Abstract] [Full Text] [Related]
12. [The depot neuroleptic agent fluspirilene (author's transl)].
Angst J; Frei M; Scharfetter Chr
Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
[No Abstract] [Full Text] [Related]
13. [Clinical trial of a neuroleptic with prolonged action (fluspirilene)].
De Francisco CP; Nieto Gómez D; Castilla J; Torres A; Avalos C
Actas Luso Esp Neurol Psiquiatr; 1971; 30(3):123-8. PubMed ID: 5145187
[No Abstract] [Full Text] [Related]
14. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
Angst J; Woggon B
Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
[TBL] [Abstract][Full Text] [Related]
15. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
Baro F; Van Lommel R; Dom R; De Mesmaecker L
Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
[No Abstract] [Full Text] [Related]
16. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
Tanghe A; Vereecken JL
Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
[No Abstract] [Full Text] [Related]
17. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic.
Van Lommel R; Baro F; Dom R
Arzneimittelforschung; 1974 Jul; 24(7):1072-4. PubMed ID: 4605278
[No Abstract] [Full Text] [Related]
18. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
[No Abstract] [Full Text] [Related]
19. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
[No Abstract] [Full Text] [Related]
20. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
McClelland HA
Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
[No Abstract] [Full Text] [Related]
[Next] [New Search]